These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17453558)

  • 1. Alzheimer's disease patients' cognitive status and course years prior to symptom recognition.
    Cerhan JH; Ivnik RJ; Smith GE; Machulda MM; Boeve BF; Knopman DS; Petersen RC; Tangalos EG
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2007 May; 14(3):227-35. PubMed ID: 17453558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease.
    Stavitsky K; Brickman AM; Scarmeas N; Torgan RL; Tang MX; Albert M; Brandt J; Blacker D; Stern Y
    Arch Neurol; 2006 Oct; 63(10):1450-6. PubMed ID: 17030662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study.
    Amieva H; Jacqmin-Gadda H; Orgogozo JM; Le Carret N; Helmer C; Letenneur L; Barberger-Gateau P; Fabrigoule C; Dartigues JF
    Brain; 2005 May; 128(Pt 5):1093-101. PubMed ID: 15774508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.
    Schrijnemaekers AM; de Jager CA; Hogervorst E; Budge MM
    J Clin Exp Neuropsychol; 2006 Apr; 28(3):438-55. PubMed ID: 16618630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive measures predict pathologic Alzheimer disease.
    Powell MR; Smith GE; Knopman DS; Parisi JE; Boeve BF; Petersen RC; Ivnik RJ
    Arch Neurol; 2006 Jun; 63(6):865-8. PubMed ID: 16769868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Face-name association learning in early Alzheimer's disease: a comparison of learning methods and their underlying mechanisms.
    Bier N; Van Der Linden M; Gagnon L; Desrosiers J; Adam S; Louveaux S; Saint-Mleux J
    Neuropsychol Rehabil; 2008 Jun; 18(3):343-71. PubMed ID: 18569747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of vascular disease on cognitive performance in the preclinical and early phases of Alzheimer's disease.
    Laukka EJ; Fratiglioni L; Bäckman L
    Dement Geriatr Cogn Disord; 2010; 29(6):498-503. PubMed ID: 20523048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and psychological symptoms in the preclinical stage of Alzheimer's disease.
    Bidzan L; Pachalska M; Grochmal-Bach B; Bidzan M; Cieslukowska A; Pufal A
    Med Sci Monit; 2008 Sep; 14(9):CR473-9. PubMed ID: 18758418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological and information processing variability predicts memory decrements associated with normal age-related cognitive decline and Alzheimer's disease (AD).
    Hogan MJ; Carolan L; Roche RA; Dockree PM; Kaiser J; Bunting BP; Robertson IH; Lawlor BA
    Brain Res; 2006 Nov; 1119(1):215-26. PubMed ID: 16997285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Placing Test: preliminary investigations of a quick and simple memory test designed to be sensitive to pre-dementia Alzheimer's disease but not to normal ageing.
    Anderson EJ; de Jager CA; Iversen SD
    J Clin Exp Neuropsychol; 2006 Aug; 28(6):843-58. PubMed ID: 16822728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The psychopathological symptoms of the preclinical stages of Alzheimer's disease].
    Bidzan L
    Psychiatr Pol; 2001; 35(6):1019-32. PubMed ID: 11877882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implicit/explicit memory dissociation in Alzheimer's disease: the consequence of inappropriate processing?
    Willems S; Salmon E; Van der Linden M
    Neuropsychology; 2008 Nov; 22(6):710-7. PubMed ID: 18999344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.
    Heidler-Gary J; Gottesman R; Newhart M; Chang S; Ken L; Hillis AE
    Dement Geriatr Cogn Disord; 2007; 23(3):184-93. PubMed ID: 17220629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When memory does not fail: familiarity-based recognition in mild cognitive impairment and Alzheimer's disease.
    Westerberg CE; Paller KA; Weintraub S; Mesulam MM; Holdstock JS; Mayes AR; Reber PJ
    Neuropsychology; 2006 Mar; 20(2):193-205. PubMed ID: 16594780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease.
    Laukka EJ; Jones S; Small BJ; Fratiglioni L; Bäckman L
    J Int Neuropsychol Soc; 2004 May; 10(3):382-91. PubMed ID: 15147596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.